Unfortunately, hepcidin and its protective role is a double-edged sword in patients with chronic inflammatory conditions, such as IBD, whereby inflammation and iron deficiency may coexist and could lead to inappropriately elevated hepcidin levels, hindering adequate response to iron therapy. This evidence concerns the gene HAMP and inflammatory bowel disease.